MARKER THERAPEUTICS, INC. Deferred Tax Liabilities, Gross
MARKER THERAPEUTICS, INC. (MRKR) had Deferred Tax Liabilities, Gross of $1.46 million as of 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2023-03-22
- 2022-12-31: Deferred Tax Liabilities, Gross $1.46M.
- 2021-12-31: Deferred Tax Liabilities, Gross $2.18M.
- 2020-12-31: Deferred Tax Liabilities, Gross $2.38M.
- 2019-12-31: Deferred Tax Liabilities, Gross $106.00K.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2022-12-31 | $1.46M 10-K · filed 2023-03-22 |
| 2021-12-31 | $2.18M 10-K · filed 2022-03-17 |
| 2020-12-31 | $2.38M 10-K · filed 2022-03-17 |
| 2019-12-31 | $106.00K 10-K · filed 2021-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |